![]() |
市場調查報告書
商品編碼
1930037
外科縫合線市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2025-2034)Surgical Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034 |
||||||
由於手術數量的增加、慢性病盛行率的上升以及縫合技術的不斷進步,全球外科縫合線市場正經歷穩定成長。 2025年,全球外科縫線市場規模為60.3億美元。預計該市場將從2026年的64.2億美元成長到2034年的115.2億美元,在預測期(2026-2034年)內,複合年增長率(CAGR)為7.57%。
預計北美將在2025年以39.44%的市場佔有率引領外科縫合線市場,這主要得益於該地區較高的手術量、先進的醫療基礎設施以及主要市場參與者的強大影響力。
外科縫合線是一種醫療器械,用於在手術期間或手術後閉合傷口和結紮血管。這些產品廣泛應用於各種手術,從剖腹產、關節置換和心血管手術等大型手術到牙科和眼科手術等小型手術。交通事故、骨科損傷和慢性疾病的日益增多,正推動全球外科手術數量的顯著增長,從而帶動了對外科縫合線的需求。
市場驅動因素
手術數量不斷增加
骨科、心血管、婦科和整形手術數量的不斷增長是推動市場成長的主要因素。例如,根據美國風濕病學會(2023年2月)的數據,美國每年約進行79萬例膝關節置換手術和45萬例髖關節置換手術。
此外,根據美國疾病管制與預防中心 (CDC) 的數據,2021 年美國共記錄了 1,174,545 例剖腹產手術,佔所有分娩的 32.1%。老年人口的增長,尤其是易患關節炎、骨折和心血管疾病的老年人口,進一步推高了手術幹預率,從而促進了市場擴張。
縫合線技術進步
先進縫合線的引入,例如無結縫合線、彈性縫合線和生物複合縫合線,改善了手術效果,並促進了其應用。這些縫合線能夠加速傷口癒合,降低感染風險,並提高抗拉強度。持續的研發投入和創新產品的監管審批正在對市場成長產生積極影響。
市場趨勢
先進智慧縫線的引入
市場的主要趨勢之一是採用技術先進的無結縫合線,以滿足尚未滿足的臨床需求。這些縫合線可以輸送藥物、檢測感染並支持有效的傷口閉合。
例如,美國食品藥物管理局 (FDA) 已授予多種無結縫合系統 510(k) 許可,包括 Anika Therapeutics 的 X-Twist 和 Smith & Nephew 的 HELICOIL 無結縫合系統。這些進步使企業能夠鞏固其市場地位,同時擴展其產品組合。
限制因子
來自其他傷口閉合產品的競爭
手術縫合器等其他傷口護理產品的激增對市場成長構成了挑戰。縫合器可以加快傷口閉合速度並縮短手術時間。此外,對縫線相關手術部位感染 (SSI) 的擔憂以及新興經濟體缺乏報銷政策可能會限制其應用。根據美國國家生物技術資訊中心 (NCBI) 的數據,每年約有 5% 的手術患者發生 SSI,這會影響外科醫生在某些手術中選擇縫線。
依產品類型
此市場細分分為可吸收縫線和不可吸收縫線。
由於其癒合速度快、抗拉強度高且減少拆線次數,可吸收縫線細分市場預計將在 2026 年佔 64.30% 的市場佔有率。監管支持進一步鞏固了該細分市場的主導地位。
依型態
依型態,市場分為合成縫線和天然縫線。
由於合成縫合線過敏反應發生率低且在醫療專業人員中普及率高,預計到2026年,合成縫合線市場佔有率將達到78.31%。
依應用領域劃分
骨科領域在2026年佔市場主導地位,市佔率為27.40%,主要得益於關節置換和骨折修復手術的增加。婦科和心臟科領域也貢獻顯著,這主要歸功於剖腹產和搭橋手術的增加。
依最終使用者劃分
醫院和門診手術中心(ASC)在2026年佔市場主導地位,市場佔有率為71.15%,這主要得益於其手術量大、設施先進以及外科醫生技術精湛。
The global surgical sutures market is witnessing steady growth driven by the rising number of surgical procedures, increasing prevalence of chronic diseases, and continuous advancements in suturing technologies. In 2025, the global surgical sutures market size was valued at USD 6.03 billion. The market is projected to grow from USD 6.42 billion in 2026 to USD 11.52 billion by 2034, registering a CAGR of 7.57% during the forecast period (2026-2034).
North America dominated the surgical sutures market with a 39.44% share in 2025, supported by a high volume of surgeries, advanced healthcare infrastructure, and strong presence of key market players.
Surgical sutures are medical devices used to close wounds and ligate blood vessels during or after surgical procedures. These products are extensively used in major surgeries such as cesarean sections, joint replacements, cardiovascular surgeries, and minor procedures including dental and ophthalmic surgeries. The growing incidence of road accidents, orthopedic injuries, and chronic disorders has significantly increased surgical volumes worldwide, thereby boosting demand for surgical sutures.
Market Drivers
Rising Number of Surgical Procedures
The increasing number of orthopedic, cardiovascular, gynecological, and cosmetic surgeries is a major factor driving market growth. For instance, data from the American College of Rheumatology (February 2023) indicates that approximately 790,000 knee replacement and 450,000 hip replacement surgeries are performed annually in the U.S.
Additionally, according to the CDC, 1,174,545 cesarean deliveries were recorded in the U.S. in 2021, accounting for 32.1% of all births. The expanding geriatric population, which is more prone to arthritis, fractures, and cardiovascular conditions, is further increasing surgical intervention rates and supporting market expansion.
Technological Advancements in Sutures
The introduction of advanced sutures, including knotless, elastic, and bio-composite sutures, is improving surgical outcomes and driving adoption. These sutures enable faster wound healing, reduced infection risk, and enhanced tensile strength. Continuous R&D investments and regulatory approvals for innovative products are positively influencing market growth.
Market Trends
Introduction of Advanced and Smart Sutures
One of the key trends in the market is the adoption of knotless and technologically advanced sutures designed to address unmet clinical needs. These sutures can deliver drugs, detect infections, and support efficient wound closure.
For instance, the U.S. FDA granted 510(k) clearance to several knotless suture systems, including Anika Therapeutics' X-Twist and Smith & Nephew's HELICOIL knotless sutures. Such advancements are enabling companies to strengthen their market position while expanding product portfolios.
Restraining Factors
Competition from Alternative Wound Closure Products
The availability of alternative wound care products such as surgical staplers poses a challenge to market growth. Staplers offer faster wound closure and reduced operation time. In addition, concerns related to surgical site infections (SSIs) associated with sutures and lack of reimbursement policies in emerging economies may limit adoption. According to NCBI data, approximately 5% of surgical patients develop SSIs annually, which impacts surgeon preference for sutures in certain procedures.
By Product Type
The market is segmented into absorbable and non-absorbable sutures.
The absorbable segment dominated with a 64.30% share in 2026, owing to faster healing, high tensile strength, and reduced need for stitch removal. Regulatory support further strengthens this segment's dominance.
By Form
Based on form, the market is divided into synthetic and natural sutures.
The synthetic segment accounted for 78.31% market share in 2026, attributed to lower hypersensitivity reactions and higher adoption by healthcare professionals.
By Application
The orthopedics segment led the market with a 27.40% share in 2026, driven by a rising number of joint replacement and fracture repair surgeries. Gynecology and cardiology also contribute significantly due to increasing cesarean and bypass procedures.
By End User
The hospitals & ASCs segment dominated with a 71.15% share in 2026, supported by high surgical volumes, advanced facilities, and skilled surgeons.
Competitive Landscape
Key players include B. Braun SE, Ethicon U.S. LLC, Medtronic, Smith & Nephew, and Coloplast A/S. These companies focus on product innovation, capacity expansion, and strategic launches to strengthen their global presence.
Conclusion
In conclusion, the global surgical sutures market is projected to grow steadily from USD 6.03 billion in 2025 to USD 11.52 billion by 2034. Rising surgical volumes, technological advancements in suturing devices, and increasing geriatric population are the key growth drivers. Although competition from alternative wound closure products and infection-related concerns pose challenges, continuous innovation and expanding healthcare infrastructure worldwide are expected to sustain long-term market growth.
Segmentation
By Product Type
By Form
By Application
By End-user
By Geography